Against the background of stimulation of tumor metastasis and the increased tolerance to ER stress and worsened prognosis in SEC62 overexpression, Sec62 presents itself as a potential target structure of a targeted antitumor therapy (Greiner et al., 2011a; Greiner et al., 2011b) (Figures 2, 4). Here, SEC62 is linked to neoplasm.